I

INmune Bio
D

INMB

4.87000
USD
-0.01
(-0.20%)
Market Closed
Volume
3,892
EPS
-2
Div Yield
-
P/E
-2
Market Cap
107,979,836
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMA
    -1.180
    (-5.84%)
    19.030 USD
    A
    AGEN
    -0.05000
    (-1.80%)
    2.72500 USD
    C
    CGEN
    -0.08000
    (-5.41%)
    1.40000 USD
    E
    EIGR
    0
    (0%)
    0.000000 USD
    G
    GTHX
    0.01000
    (0.14%)
    7.16000 USD
    I
    IMV
    0.01000
    (1.96%)
    0.51000 USD
    More
News

Title: INmune Bio

Sector: Healthcare
Industry: Biotechnology
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.